Key Takeaways Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's ...
More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...
In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...
A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...